Global Medical REIT Inc.
Символ: GMRE
NYSE
9.03
USDПазарна цена днес
25.7972
Съотношение P/E
0.4936
Коефициент PEG
592.14M
MRK Cap
- 0.10%
Доходност на DIV
Global Medical REIT Inc. (GMRE) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 15.74 | 7.4 | 4 | 7.2 | |||||||||||||
balance-sheet.row.short-term-investments | 126.8 | 25.1 | 34.7 | 1.2 | |||||||||||||
balance-sheet.row.net-receivables | 57.02 | 33.7 | 8.2 | 6.2 | |||||||||||||
balance-sheet.row.inventory | -126.8 | -25.1 | -34.7 | -1.2 | |||||||||||||
balance-sheet.row.other-current-assets | -206.57 | -41.1 | 18.3 | -50.3 | |||||||||||||
balance-sheet.row.total-current-assets | 97.25 | 14.4 | 30.5 | 24.9 | |||||||||||||
balance-sheet.row.property-plant-equipment-net | 30.08 | 7.6 | 3.5 | 3.8 | |||||||||||||
balance-sheet.row.goodwill | 23.61 | 5.9 | 5.9 | 5.9 | |||||||||||||
balance-sheet.row.intangible-assets | 492.55 | 66 | 148.1 | 127.9 | |||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 516.16 | 71.9 | 154 | 133.8 | |||||||||||||
balance-sheet.row.long-term-investments | 126.8 | 25.1 | 34.7 | 1.2 | |||||||||||||
balance-sheet.row.tax-assets | 1038.58 | 1140.3 | -34.7 | -1.2 | |||||||||||||
balance-sheet.row.other-non-current-assets | 3451.18 | 8.5 | 1205.3 | 1100.9 | |||||||||||||
balance-sheet.row.total-non-current-assets | 5162.81 | 1253.3 | 1362.7 | 1238.5 | |||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.total-assets | 5260.06 | 1267.7 | 1393.3 | 1263.5 | |||||||||||||
balance-sheet.row.account-payables | 54.14 | 12.8 | 13.8 | 10.3 | |||||||||||||
balance-sheet.row.short-term-debt | 1763.97 | 0.4 | 636.4 | 514.6 | |||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.long-term-debt-total | 782.14 | 610.8 | 57.7 | 57.2 | |||||||||||||
Deferred Revenue Non Current | 19.58 | 5.1 | 4.4 | 3.2 | |||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | -620.46 | - | - | - | |||||||||||||
balance-sheet.row.other-current-liab | 634.53 | 601.1 | 11.4 | 15.7 | |||||||||||||
balance-sheet.row.total-non-current-liabilities | 278.51 | 42.5 | 78.1 | 85.3 | |||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.capital-lease-obligations | 30.98 | 13 | 10.5 | 8.1 | |||||||||||||
balance-sheet.row.total-liab | 2750.73 | 661.9 | 744.2 | 625.9 | |||||||||||||
balance-sheet.row.preferred-stock | 299.84 | 75 | 75 | 75 | |||||||||||||
balance-sheet.row.common-stock | 0.26 | 0.1 | 0.1 | 0.1 | |||||||||||||
balance-sheet.row.retained-earnings | -888.9 | -239 | -198.7 | -157 | |||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 126.77 | 25.1 | 34.7 | -6.6 | |||||||||||||
balance-sheet.row.other-total-stockholders-equity | 2889.37 | 722.4 | 722 | 711.4 | |||||||||||||
balance-sheet.row.total-stockholders-equity | 2427.34 | 583.6 | 633 | 622.8 | |||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 5260.06 | 1267.7 | 1393.3 | 1263.5 | |||||||||||||
balance-sheet.row.minority-interest | 81.99 | 22.2 | 16.1 | 14.8 | |||||||||||||
balance-sheet.row.total-equity | 2509.33 | 605.8 | 649.1 | 637.6 | |||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 5260.06 | - | - | - | |||||||||||||
Total Investments | 126.8 | 25.1 | 34.7 | 1.2 | |||||||||||||
balance-sheet.row.total-debt | 2559.07 | 624.2 | 694.1 | 571.7 | |||||||||||||
balance-sheet.row.net-debt | 2543.33 | 616.8 | 690.1 | 564.5 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 21.8 | 20.6 | 20 | 18.3 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 58.84 | 58.1 | 57.7 | 47.3 | ||||||||||||
cash-flows.row.deferred-income-tax | -46.04 | -122.1 | 0 | -0.9 | ||||||||||||
cash-flows.row.stock-based-compensation | 4.24 | 4.2 | 4.7 | 5.8 | ||||||||||||
cash-flows.row.change-in-working-capital | -5.69 | -5.7 | -1.7 | -3.8 | ||||||||||||
cash-flows.row.account-receivables | 0.43 | 0.4 | -3 | -0.7 | ||||||||||||
cash-flows.row.inventory | -0.37 | 0 | 0 | 0.2 | ||||||||||||
cash-flows.row.account-payables | -2.02 | -2 | 4.1 | 1.9 | ||||||||||||
cash-flows.row.other-working-capital | -3.73 | -4.1 | -2.8 | -5.3 | ||||||||||||
cash-flows.row.other-non-cash-items | 35.3 | 113.3 | -4.1 | 2.2 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 68.44 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -10.05 | -10 | -156.2 | -201.7 | ||||||||||||
cash-flows.row.acquisitions-net | 1.04 | 0 | 2 | 2.8 | ||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -2 | -2.8 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 26.91 | 86.1 | 11.1 | 4.4 | ||||||||||||
cash-flows.row.other-investing-activites | 57.91 | -1.3 | 7.8 | 2.6 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 75.81 | 74.8 | -137.3 | -194.7 | ||||||||||||
cash-flows.row.debt-repayment | -124.19 | -86.1 | -16.7 | -232.2 | ||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 9.9 | 205.5 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 221.6 | ||||||||||||
cash-flows.row.dividends-paid | -64.85 | -64.8 | -64.2 | -58.3 | ||||||||||||
cash-flows.row.other-financing-activites | 45.25 | 0 | 133.4 | -8.9 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -151.99 | -150.9 | 62.4 | 127.7 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 9.47 | -77.5 | 0 | 0 | ||||||||||||
cash-flows.row.net-change-in-cash | -16.92 | -14.9 | 1.7 | 2 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 38.77 | 7.4 | 14.5 | 12.8 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 55.69 | 22.3 | 12.8 | 10.8 | ||||||||||||
cash-flows.row.operating-cash-flow | 68.44 | 68.4 | 76.5 | 69 | ||||||||||||
cash-flows.row.capital-expenditure | -10.05 | -10 | -156.2 | -201.7 | ||||||||||||
cash-flows.row.free-cash-flow | 58.39 | 58.4 | -79.7 | -132.7 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 145.48 | 156.7 | 137.3 | 115.9 | ||||||||||||
income-statement-row.row.cost-of-revenue | 42.33 | 86.2 | 25.2 | 15.5 | ||||||||||||
income-statement-row.row.gross-profit | 103.15 | 70.4 | 112.1 | 100.4 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 16.85 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 10.72 | -16.9 | 56.7 | 46.9 | ||||||||||||
income-statement-row.row.operating-expenses | 60.74 | 16.9 | 73.3 | 63.3 | ||||||||||||
income-statement-row.row.cost-and-expenses | 103.07 | 103.1 | 98.5 | 78.8 | ||||||||||||
income-statement-row.row.interest-income | 23.91 | 0 | 25.2 | 19.7 | ||||||||||||
income-statement-row.row.interest-expense | 35.38 | 46.5 | 25.2 | 19.7 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | -5.04 | -31.8 | -18.8 | -18.8 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 10.72 | -16.9 | 56.7 | 46.9 | ||||||||||||
income-statement-row.row.total-operating-expenses | -5.04 | -31.8 | -18.8 | -18.8 | ||||||||||||
income-statement-row.row.interest-expense | 35.38 | 46.5 | 25.2 | 19.7 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 58.4 | 58.1 | 57.7 | 46.9 | ||||||||||||
income-statement-row.row.ebitda-caps | 100.87 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | 59.06 | 53.5 | 38.8 | 37.1 | ||||||||||||
income-statement-row.row.income-before-tax | 21.73 | 21.7 | 20 | 18.3 | ||||||||||||
income-statement-row.row.income-tax-expense | 16.37 | 1.1 | 25.2 | 20.4 | ||||||||||||
income-statement-row.row.net-income | 20.61 | 20.6 | -5.2 | -2.1 |
Често задавани въпроси
Какво е Global Medical REIT Inc. (GMRE) общи активи?
Global Medical REIT Inc. (GMRE) общите активи са 1267700000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 72935000.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 0.891.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 0.891.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е 0.142.
Какъв е общият приход на предприятието?
Общият приход е 0.406.
Каква е Global Medical REIT Inc. (GMRE) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 20612000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 624193000.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 16897000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 7397000.000.